Search results
May 6, 2022 · Approximately 200,000 people around the world have cone-rod dystrophy. In the study, mice with CDHR1 mutations were treated with a gene therapy that used an adeno-associated virus serotype 8 (AAV8), a safe, human-engineered virus, to deliver healthy copies of CDHR1 to cells in the retina.
Cone-rod dystrophy (CRD) is a group of inherited eye disorders that affect the light sensitive cells of the retina called the cones and rods. People with this condition experience vision loss over time as the cones and rods deteriorate.
Jun 14, 2021 · Treatment. There is no cure for cone dystrophy. Treatment is directed toward the specific symptoms that are apparent in each individual. Treatment may include using tinted lenses or dark sunglass in bright environments and magnifying devices to assist in reading and other similar activities.
Jan 24, 2019 · We discuss the genetics, and clinical, psychophysical, electrophysiological and retinal imaging characteristics of cone and cone-rod dystrophies, focusing particularly on four of the most common disease-associated genes: GUCA1A, PRPH2, ABCA4 and RPGR.
The relative sparing of rod function in cone dystrophy is evidenced by a normal scotopic ERG, i.e. when the test is carried out in the dark. In more severe or longer standing cases, the dystrophy involves a greater proportion of rods with resultant subnormal scotopic records.
Nov 30, 2020 · There are no approved treatments for cone/cone-rod dystrophy at present. Current management is focused on alleviating symptoms and optimising remaining sight by treating the other eye conditions associated with cone/cone-rod dystrophy.
Cone-rod dystrophy is a group of related eye disorders that causes vision loss, which becomes more severe over time. Explore symptoms, inheritance, genetics of this condition.
